SCHEMBL22014915

SCHEMBL22014915

CC(C)(O)c1csc(C(N)=O)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
SCN9A Q15858 1/20 0.33
ATAD2 Q6PL18 1/20 0.33
ALDH1A1 P00352 4/20 0.32
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK1 P28482 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
TAS1R2 Q8TE23 1/20 0.32
HCRTR2 O43614 6/20 0.32
LMNA P02545 3/20 0.32
NLRP3 Q96P20 1/20 0.32
PKMYT1 Q99640 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2677290 0.87 ATAD2 (0.43) ATAD2ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL577680 0.79 CYP3A4 (0.39) CYP3A4CYP2D6CYP2C9SCN9AALDH1A1
SCHEMBL28316717 0.75 HCRTR2 (0.33) ATAD2ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL28883226 0.74 KMT2A (0.38) CYP3A4CYP2D6CYP2C9SCN9AALDH1A1
SCHEMBL3605034 0.72 SMN1; SMN2 (0.46) CYP3A4CYP2D6CYP2C9ALDH1A1NPC1
SCHEMBL148961 0.72
Hydrochloric Acid SCHEMBL4139453 0.71 SMN1; SMN2 (0.45) NPC1RAB9ASMN1; SMN2KMT2APOLB
Hydrochloric Acid SCHEMBL4139458 0.71 SMN1; SMN2 (0.45) NPC1RAB9ASMN1; SMN2KMT2APOLB
SCHEMBL13412495 0.70 ALDH1A1 (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL25308644 0.70 KDM4E (0.33) ATAD2NPC1RAB9ASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed